Further development of the new antiviral agent for protection against enveloped viruses (HIV, HSV-1, HSV-2, SARS-CoV-2, Influenza).
SavAntiVir: New antiviral agent
Company: SavAntiVir
Project name: New antiviral agent
Town: Belgrade
Industry: Life Sciences
Project value: EUR 115,200
IF participation: EUR 80,000
